GB983810A - Improved tablet - Google Patents
Improved tabletInfo
- Publication number
- GB983810A GB983810A GB1882963A GB1882963A GB983810A GB 983810 A GB983810 A GB 983810A GB 1882963 A GB1882963 A GB 1882963A GB 1882963 A GB1882963 A GB 1882963A GB 983810 A GB983810 A GB 983810A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sections
- section
- intersection
- upper face
- tablets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/50—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by shape, structure or physical form, e.g. products with supported structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
983,810. Medicinal tablets. WARNER-LAMBERT PHARMACEUTICAL CO. May 13, 1963, No. 18829/63. Heading A5B. A unitary tablet comprises a plurality of divisible sections in which each section has an upper face 6 (Fig. 1) and a lower face 5, the plane of the upper face of one section 7 intersecting the plane of the upper face of the other section 8 at an angle of less than 180 degrees, said sections normally being joined at said intersection 9 but being readily separated at said intersection by the application of a pressure to the junction formed at said intersection. In a modification (Fig. 2) the planes of both the upper faces 10 and lower faces 11 of each section intersect each other at an angle of less than 180 degrees. A single dosage unit for subdivision into four dosage units is shown in Fig. 3, the four sections 17, 18, 19 and 20 being divisable along the line 21 and also by scoring to separate the surfaces of sections 17 and 18 from the surfaces of sections 20 and 19. The tablet form is particularly suitable for hard, wax-containing tablets. Examples disclose tablets containing (a) N-acetyl-p-aminophenol, salicylamide, acetophenetidin, caffeine, phenylephrine hydrochloride, thonzylamine hydrochloride, calcium sulphate and ascorbic acid, (b) pentaerythritol tetranitrate and phenobarbital, (c) theophylline anhydrous, ephedrine hydrochloride and phenobarbital.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEW0034607 | 1963-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB983810A true GB983810A (en) | 1965-02-17 |
Family
ID=7600649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1882963A Expired GB983810A (en) | 1963-05-28 | 1963-05-13 | Improved tablet |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE632692A (en) |
DE (1) | DE1492237A1 (en) |
GB (1) | GB983810A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4454108A (en) * | 1981-09-04 | 1984-06-12 | Chugai Seiyaku Kabushiki Kaisha | Prolonged-action multiple-layer tablets |
EP0126453A2 (en) * | 1983-05-19 | 1984-11-28 | Merrell Dow Pharmaceuticals Inc. | Controlled release tablet |
AU587255B2 (en) * | 1985-06-04 | 1989-08-10 | Sandoz Ltd. | Pharmaceutical tablet |
GB2518955A (en) * | 2013-08-07 | 2015-04-08 | Kraft Foods R & D Inc | Comestible product |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4353887A (en) * | 1979-08-16 | 1982-10-12 | Ciba-Geigy Corporation | Divisible tablet having controlled and delayed release of the active substance |
DE3314003A1 (en) * | 1983-04-18 | 1984-10-18 | Boehringer Ingelheim KG, 6507 Ingelheim | DIVISIBLE TABLET WITH DELAYED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF |
DE19837684A1 (en) * | 1998-08-19 | 2000-02-24 | Knoll Ag | Tablet comprises two faces, mantle surface, non-planar surfaces and breakage grooves on each face |
-
0
- BE BE632692D patent/BE632692A/xx unknown
-
1963
- 1963-05-13 GB GB1882963A patent/GB983810A/en not_active Expired
- 1963-05-28 DE DE19631492237 patent/DE1492237A1/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4454108A (en) * | 1981-09-04 | 1984-06-12 | Chugai Seiyaku Kabushiki Kaisha | Prolonged-action multiple-layer tablets |
EP0126453A2 (en) * | 1983-05-19 | 1984-11-28 | Merrell Dow Pharmaceuticals Inc. | Controlled release tablet |
EP0126453A3 (en) * | 1983-05-19 | 1986-07-09 | Merrell Dow Pharmaceuticals Inc. | Controlled release tablet |
AU567940B2 (en) * | 1983-05-19 | 1987-12-10 | Merrell Dow Pharmaceuticals Inc. | Controlled release tablet |
AU587255B2 (en) * | 1985-06-04 | 1989-08-10 | Sandoz Ltd. | Pharmaceutical tablet |
GB2518955A (en) * | 2013-08-07 | 2015-04-08 | Kraft Foods R & D Inc | Comestible product |
GB2518955B (en) * | 2013-08-07 | 2020-05-27 | Kraft Foods Schweiz Holding Gmbh | Comestible product |
EP3030089B1 (en) * | 2013-08-07 | 2020-10-28 | Kraft Foods Schweiz Holding GmbH | Comestible product |
Also Published As
Publication number | Publication date |
---|---|
DE1492237A1 (en) | 1969-09-18 |
BE632692A (en) |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR830001639A (en) | Multi-segmented tablet structure | |
GB1204580A (en) | Pharmaceutical dosage forms | |
GB983810A (en) | Improved tablet | |
GB1221393A (en) | Improvements in or relating to hepato-protective drugs | |
DE2963990D1 (en) | Analgesic tablet and process for its preparation | |
ES2088550T3 (en) | COATINGS THAT HIDE THE FLAVOR TO PREPARE CHEWABLE PHARMACEUTICAL TABLETS. | |
GB1502873A (en) | Pharmaceutical compositions with ulcer healing activity | |
IL51360A (en) | Peptides having analgesic activity,their production and pharmaceutical compositions containing them | |
GB1174051A (en) | Aminophenol Derivatives and Analgesic and Antipyretic Compositions | |
FR1259081A (en) | Process for the preparation of a product with dry particles, in particular from a colloidal solution | |
GB1291559A (en) | N-(4-chlorocinnamoyl)-4-hydroxypiperidine | |
GB1195534A (en) | Drug Packs | |
GB1442159A (en) | Pharmaceutical compositions containing paracetamol | |
GB1387643A (en) | Divisible tablet | |
GB1126153A (en) | Novel polygalacturonic acid derivative | |
GB1185335A (en) | A method for producing Protease | |
SACHS et al. | Neurodermatitic reaction | |
IE35419B1 (en) | Muscle-relaxant compositions | |
GB1153324A (en) | Sustained Release Tablets | |
GB1021070A (en) | A new triazolone and a process for its preparation | |
GB1212115A (en) | Pharmaceutical composition comprising magnesium acetylsalicylate and method for preparing same | |
FR2293205A2 (en) | MEDICINAL PRODUCT USEFUL IN PARTICULAR AS A VASODILATOR, PROCESS FOR THE PREPARATION OF ITS ACTIVE SUBSTANCES AND THESE SUBSTANCES THEY SELF | |
BE747274R (en) | METHODS FOR THE PREPARATION OF N-SUBSTITUTE AND N, N-DISUBSTITUTED AMINOCARBONYLALKYL COMPOUNDS AND NEW PRODUCTS THUS OBTAINED | |
GB1285361A (en) | Improvements in or relating to pyrazolidine derivatives | |
GB1297130A (en) |